Two former Alexion executives, both of whom resigned in the middle of a scandal two years ago, are starting a new biotech company — one with ambitious goals in cell and gene therapy, according to a new slide deck obtained by STAT.
The presentation provides some of the first details about the secretive new company, which its founders, including David Hallal and Vikas Sinha, are calling ElevateBio. They haven’t yet publicly discussed its existence or launched a website.
I fail to see why this is newsworthy. So two guys resign from Alexion and might or might not be guilty of something (article does not make it clear) but stat decides to leak a slide deck with “confidential and proprietary” marked on every slide showing a detailed map of the lab space and offices (with potential security implications for everyone that works there).
Comments are closed.